Trials / Completed
CompletedNCT01895634
Reperfuse Ischemic Vessels With Endovascular Recanalization Device in JAPAN (RIVER JAPAN)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 49 (actual)
- Sponsor
- Johnson & Johnson K.K. Medical Company · Industry
- Sex
- All
- Age
- 20 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
The main objective of this study is to document that the thrombectomy catheter (Rev-01) is effective and safe when used for revascularization in subjects with acute ischemic stroke within 8 hours of symptom onset who are ineligible for treatment with IV t-PA, or in whom treatment with IV t-PA has been ineffective.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Rev-01 | Treatment arm patients have used Rev-01 at least once |
Timeline
- Start date
- 2013-05-01
- Primary completion
- 2014-11-01
- Completion
- 2014-11-01
- First posted
- 2013-07-10
- Last updated
- 2016-03-07
- Results posted
- 2016-02-05
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT01895634. Inclusion in this directory is not an endorsement.